Hana Biosciences
Biopharmaceutical company developing and commercializing differentiated cancer therapies
About Hana Biosciences
Hana Biosciences is a pharmaceutical company dedicated to developing effective cancer therapies. Operating in the oncology sector, the company focuses on creating innovative solutions for the diagnosis, treatment, and prevention of various cancers. Hana Biosciences serves healthcare providers and patients who are in need of advanced cancer treatments. The company operates in the highly specialized market of bioscience pharmaceuticals, where precision equipment and cutting-edge research are essential for eliminating cancerous cells.
The business model of Hana Biosciences involves extensive research and development (R&D) to create new cancer therapies, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the sale of these therapies to hospitals, clinics, and healthcare providers. Additionally, the company may engage in partnerships and collaborations with other pharmaceutical firms to expand its reach and capabilities.
Hana Biosciences makes money primarily through the commercialization of its cancer treatment products, licensing agreements, and potential milestone payments from collaborative ventures.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Open positions
- None listed
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Jun 2010 | $100M | — | Warburg Pincus | — |
| LATE VCOther financing | Oct 2009 | $16M | $65M | Undisclosed | — |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hana Biosciences in the San Francisco ecosystem
The Hana Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hana Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hana Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









